Cargando…
Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. Definitive diagnosis of the progressive form, non-alcoholic steatohepatitis (NASH), requires liver biopsy, which is highly invasive and unsuited to early disease or tracking changes. Inadequate performance of current...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773667/ https://www.ncbi.nlm.nih.gov/pubmed/35052873 http://dx.doi.org/10.3390/biomedicines10010195 |
_version_ | 1784636150057533440 |
---|---|
author | Newman, Lauren A. Useckaite, Zivile Johnson, Jillian Sorich, Michael J. Hopkins, Ashley M. Rowland, Andrew |
author_facet | Newman, Lauren A. Useckaite, Zivile Johnson, Jillian Sorich, Michael J. Hopkins, Ashley M. Rowland, Andrew |
author_sort | Newman, Lauren A. |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. Definitive diagnosis of the progressive form, non-alcoholic steatohepatitis (NASH), requires liver biopsy, which is highly invasive and unsuited to early disease or tracking changes. Inadequate performance of current minimally invasive tools is a critical barrier to managing NAFLD burden. Altered circulating miRNA profiles show potential for minimally invasive tracking of NAFLD. The selective isolation of the circulating extracellular vesicle subset that originates from hepatocytes presents an important opportunity for improving the performance of miRNA biomarkers of liver disease. The expressions of miR-122, -192, and -128-3p were quantified in total cell-free RNA, global EVs, and liver-specific EVs from control, NAFL, and NASH subjects. In ASGR1+ EVs, each miR biomarker trended positively with disease severity and expression was significantly higher in NASH subjects compared with controls. The c-statistic defining the performance of ASGR1+ EV derived miRNAs was invariably >0.78. This trend was not observed in the alternative sources. This study demonstrates the capacity for liver-specific isolation to transform the performance of EV-derived miRNA biomarkers for NAFLD, robustly distinguishing patients with NAFL and NASH. |
format | Online Article Text |
id | pubmed-8773667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87736672022-01-21 Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease Newman, Lauren A. Useckaite, Zivile Johnson, Jillian Sorich, Michael J. Hopkins, Ashley M. Rowland, Andrew Biomedicines Article Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. Definitive diagnosis of the progressive form, non-alcoholic steatohepatitis (NASH), requires liver biopsy, which is highly invasive and unsuited to early disease or tracking changes. Inadequate performance of current minimally invasive tools is a critical barrier to managing NAFLD burden. Altered circulating miRNA profiles show potential for minimally invasive tracking of NAFLD. The selective isolation of the circulating extracellular vesicle subset that originates from hepatocytes presents an important opportunity for improving the performance of miRNA biomarkers of liver disease. The expressions of miR-122, -192, and -128-3p were quantified in total cell-free RNA, global EVs, and liver-specific EVs from control, NAFL, and NASH subjects. In ASGR1+ EVs, each miR biomarker trended positively with disease severity and expression was significantly higher in NASH subjects compared with controls. The c-statistic defining the performance of ASGR1+ EV derived miRNAs was invariably >0.78. This trend was not observed in the alternative sources. This study demonstrates the capacity for liver-specific isolation to transform the performance of EV-derived miRNA biomarkers for NAFLD, robustly distinguishing patients with NAFL and NASH. MDPI 2022-01-17 /pmc/articles/PMC8773667/ /pubmed/35052873 http://dx.doi.org/10.3390/biomedicines10010195 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Newman, Lauren A. Useckaite, Zivile Johnson, Jillian Sorich, Michael J. Hopkins, Ashley M. Rowland, Andrew Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease |
title | Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease |
title_full | Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease |
title_fullStr | Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease |
title_full_unstemmed | Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease |
title_short | Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease |
title_sort | selective isolation of liver-derived extracellular vesicles redefines performance of mirna biomarkers for non-alcoholic fatty liver disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773667/ https://www.ncbi.nlm.nih.gov/pubmed/35052873 http://dx.doi.org/10.3390/biomedicines10010195 |
work_keys_str_mv | AT newmanlaurena selectiveisolationofliverderivedextracellularvesiclesredefinesperformanceofmirnabiomarkersfornonalcoholicfattyliverdisease AT useckaitezivile selectiveisolationofliverderivedextracellularvesiclesredefinesperformanceofmirnabiomarkersfornonalcoholicfattyliverdisease AT johnsonjillian selectiveisolationofliverderivedextracellularvesiclesredefinesperformanceofmirnabiomarkersfornonalcoholicfattyliverdisease AT sorichmichaelj selectiveisolationofliverderivedextracellularvesiclesredefinesperformanceofmirnabiomarkersfornonalcoholicfattyliverdisease AT hopkinsashleym selectiveisolationofliverderivedextracellularvesiclesredefinesperformanceofmirnabiomarkersfornonalcoholicfattyliverdisease AT rowlandandrew selectiveisolationofliverderivedextracellularvesiclesredefinesperformanceofmirnabiomarkersfornonalcoholicfattyliverdisease |